Top Markets
Coin of the day
XORTX Therapeutics Inc. XORTX Therapeutics Inc.

XORTX Therapeutics Inc.

XRTX
Rangering i aksjer #39280
Based in Vancouver, Canada, XORTX Therapeutics Inc. is a biopharmaceutical firm... Based in Vancouver, Canada, XORTX Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering and bringing to market treatments for a variety of conditions, including progressive kidney disorders, diabetes, insulin resistance, metabolic syndrome, and infections. The company's pipeline includes XRx-008, a late-stage clinical program addressing autosomal dominant polycystic kidney disease; XRx-101, an agent designed to reduce uric acid levels in COVID-19 patients to prevent acute kidney injury and its associated health issues; and XRx-221, a series of xanthine oxidase inhibitor candidates aimed at treating diabetic nephropathy. Furthermore, XORTX Therapeutics collaborates with the Icahn School of Medicine to research the occurrence of acute kidney injury and elevated uric acid in patients hospitalized with COVID-19.
Aksjekurs
$2.06
Sist synkronisert: 2026-08-11
Markedsverdi
$572.30K
Endring (1 dag)
0.00%
Endring (1 år)
-90.38%
Land
CA
Handel XORTX Therapeutics Inc. (XRTX)

Kategori

Aksjeprishistorikk for XORTX Therapeutics Inc. (XRTX)
Høyeste sluttskurs: $2.06 den 2026-08-01

Laveste sluttskurs: $173.60 den 2015-10-01
Aksjeprishistorikk for XORTX Therapeutics Inc. fra 2015 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -27.44%
2025 -48.32%
2024 -50.05%
2023 -69.00%
2022 -58.91%
2021 105.10%
2020 -34.17%
2019 8.63%
2018 152.77%
2017 -20.67%
2016 22.14%
2015 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$517.18 32.51%
US
$857.76 31.47%
NL
$728.31 6.63%
CH
$1.07K -6.40%
KR
$254.43 12.40%
BE